| Announce Date | 10/06/2025 | 
| EPS Normalized Actual | $3.63 (Beat by $0.26) | 
| EPS GAAP Actual | $3.63 (Beat by $0.26) | 
| Revenue Actual | $2.481B | 
| Revenue Surprise | Beat by $2481M | 
| Announce Date | 12/31/1969 (Pre-Market) | 
| EPS Normalized Estimate | $ | 
| EPS GAAP Estimate | $ | 
| Revenue Estimate | $0B | 
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| Feb 2030 | 18.5 | 6.97 | 16.89239 | 19.67263 | 1 | 
| Mar 2029 | 22.54 | 5.72 | 22.2019 | 22.80094 | 1 | 
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss | 
|---|---|---|---|---|---|
| FQ3 2025 (Aug 2025) | 2.65 | 2.65 | 2.481B | -17.65% | 2481M | 
| FQ2 2025 (May 2025) | 2.9 | 2.9 | 2.515B | -5.83% | 2515M | 
| FQ1 2025 (Feb 2025) | -2.09 | -2.09 | 2.1642B | 1.16% | 2164.2M | 
| FQ4 2024 (Nov 2024) | 3.4 | 3.4 | 2.4638B | -0.29% | 2463.8M | 
| FQ3 2024 (Aug 2024) | -6.59 | -6.59 | 2.9189B | 2.81% | 2918.9M | 
| FQ2 2024 (May 2024) | 4.8 | 4.8 | 2.6617B | 5.52% | 2661.7M | 
| FQ1 2024 (Feb 2024) | 2.15 | 2.15 | 2.1392B | 100% | 2139.2M | 
| FQ4 2023 (Nov 2023) | 2.77 | 2.77 | 2.4709B | 100% | 2470.9M | 
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 3.0791 | -- | 3.0791 | 3.0791 | 8 | 
| FQ4 2027 (Nov 2027) | 4.022 | -- | 3.86266 | 4.1059 | 7 | 
| FQ3 2027 (Aug 2027) | 5.4913 | -- | 5.27375 | 5.60586 | 10 | 
| FQ2 2027 (May 2027) | 4.5053 | -- | 4.32681 | 4.59929 | 7 | 
| FQ1 2027 (Mar 2027) | 3.16632 | -- | 3.10493 | 3.25066 | 4 | 
| FQ4 2026 (Nov 2026) | 3.71126 | -- | 3.56423 | 3.78868 | 7 | 
| FQ3 2026 (Aug 2026) | 4.87139 | 45.6 | 4.76928 | 4.93305 | 6 | 
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 2.47B | -- | 2.47B | 2.47B | 4 | 
| FQ4 2027 (Nov 2027) | 2.86B | -- | 2.78B | 2.91B | 8 | 
| FQ3 2027 (Aug 2027) | 3.42B | -- | 3.31B | 3.47B | 8 | 
| FQ2 2027 (May 2027) | 3.11B | -- | 3.01B | 3.16B | 8 | 
| FQ1 2027 (Mar 2027) | 2.59B | -- | 2.55B | 2.64B | 5 | 
| FQ4 2026 (Nov 2026) | 2.67B | -- | 2.59B | 2.71B | 8 | 
| FQ3 2026 (Aug 2026) | 3.43B | 27.6 | 3.37B | 3.46B | 5 | 
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ3 2025 (Aug 2025) | 2.65 | 2.65 | 100% | |
| FQ2 2025 (May 2025) | 2.9 | 2.9 | 100% | |
| FQ1 2025 (Feb 2025) | -2.09 | -2.09 | 100% | |
| FQ4 2024 (Nov 2024) | 3.4 | 3.4 | 100% | |
| FQ3 2024 (Aug 2024) | -6.59 | -6.59 | 100% | |
| FQ2 2024 (May 2024) | 4.8 | 4.8 | 100% | |
| FQ1 2024 (Feb 2024) | 2.15 | 2.15 | 100% | |
| FQ4 2023 (Nov 2023) | 2.77 | 2.77 | 100% | 
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ3 2025 (Aug 2025) | $0B | $2.48B | $2481M | 100% | 
| FQ2 2025 (May 2025) | $0B | $2.52B | $2515M | 100% | 
| FQ1 2025 (Feb 2025) | $0B | $2.16B | $2164.2M | 100% | 
| FQ4 2024 (Nov 2024) | $0B | $2.46B | $2463.8M | 100% | 
| FQ3 2024 (Aug 2024) | $0B | $2.92B | $2918.9M | 100% | 
| FQ2 2024 (May 2024) | $0B | $2.66B | $2661.7M | 100% | 
| FQ1 2024 (Feb 2024) | $0B | $2.14B | $2139.2M | 100% | 
| FQ4 2023 (Nov 2023) | $0B | $2.47B | $2470.9M | 100% |